ATE250920T1 - Verwendung von n-acetyl-l-cystein zur aufhellung von hyperpigmentierter haut - Google Patents

Verwendung von n-acetyl-l-cystein zur aufhellung von hyperpigmentierter haut

Info

Publication number
ATE250920T1
ATE250920T1 AT95924580T AT95924580T ATE250920T1 AT E250920 T1 ATE250920 T1 AT E250920T1 AT 95924580 T AT95924580 T AT 95924580T AT 95924580 T AT95924580 T AT 95924580T AT E250920 T1 ATE250920 T1 AT E250920T1
Authority
AT
Austria
Prior art keywords
acid
acetyl
cystein
skin
cysteine
Prior art date
Application number
AT95924580T
Other languages
English (en)
Inventor
Greg George Hillebrand
Original Assignee
Textile Res Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Textile Res Inst Inc filed Critical Textile Res Inst Inc
Application granted granted Critical
Publication of ATE250920T1 publication Critical patent/ATE250920T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/447—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Collating Specific Patterns (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
AT95924580T 1994-06-15 1995-06-12 Verwendung von n-acetyl-l-cystein zur aufhellung von hyperpigmentierter haut ATE250920T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25980494A 1994-06-15 1994-06-15
PCT/US1995/007432 WO1995034280A1 (en) 1994-06-15 1995-06-12 Methods of lightening hyperpigmented regions in mammalian skin

Publications (1)

Publication Number Publication Date
ATE250920T1 true ATE250920T1 (de) 2003-10-15

Family

ID=22986467

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95924580T ATE250920T1 (de) 1994-06-15 1995-06-12 Verwendung von n-acetyl-l-cystein zur aufhellung von hyperpigmentierter haut

Country Status (12)

Country Link
EP (1) EP0758882B1 (de)
JP (1) JPH10501817A (de)
KR (1) KR970703749A (de)
CN (1) CN1152865A (de)
AT (1) ATE250920T1 (de)
AU (1) AU705904B2 (de)
CA (1) CA2192665C (de)
CZ (1) CZ365996A3 (de)
DE (1) DE69531863D1 (de)
MX (1) MX9606508A (de)
TW (1) TW452493B (de)
WO (1) WO1995034280A1 (de)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5690944A (en) * 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
US5691380A (en) * 1995-06-29 1997-11-25 The Procter & Gamble Company Stable n-acetylcysteine compositions and methods for treating human skin therewith
FR2750332B1 (fr) * 1996-06-28 1998-09-11 Sincholle Daniel Paul Composition pour la prevention et le traitement topique de la cellulite
DE19635579A1 (de) * 1996-09-02 1998-03-26 Karlsruhe Forschzent Mittel zur Pflege und zum Schutz der Haut
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
GB9620503D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
WO1998034591A1 (en) * 1997-02-11 1998-08-13 The Procter & Gamble Company Skin lightening compositions
IT1291622B1 (it) * 1997-04-18 1999-01-11 Marcello Izzo Uso dell'acido tioglicolico come agente depigmentante
USH2043H1 (en) 1997-05-23 2002-08-06 The Procter & Gamble Company Skin care compositions
US6077503A (en) * 1997-07-30 2000-06-20 Amway Corporation Skin whitener composition containing mercaptodextran
US5965618A (en) * 1997-11-17 1999-10-12 Perricone; Nicholas V. Treatment of scar tissue using lipoic acid
FR2804862B1 (fr) * 2000-02-10 2002-06-07 Fabre Pierre Dermo Cosmetique Compositions cosmetiques a base de derives thiosalicyliques et nouveaux derives thiosalicyliques de type quinolylique
FR2804960B1 (fr) * 2000-02-11 2005-06-24 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants
US8360973B2 (en) 2000-11-29 2013-01-29 L'oreal Process for acquiring scanned image data relating to an external body portion and/or a product applied thereto
DE10111039A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus alpha-Liponsäure und dermatologisch verträglichen Substanzen, die Lichtabsorption im UV-A-Bereich und/oder UV-B-Bereich zeigen, zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe der Symptome der intrinsischen und/oder extrinsischen Hautalterung sowie zur Behandlung und Prophylaxe der schädlichen Auwirkungen ultravioletter Strahlung auf die Haut
DE10111046A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von Wirkstoffkombinationen aus alpha-Liponsäure und dermatologisch verträglichen Substanzen, die Lichtabsorption im UV-A-Bereich und/oder UV-B-Bereich zeigen,zur Herstellung von kosmetischen oder dermatologischen Zubereitungen zur Behandlung und/oder Prophylaxe unerwünschter Hautpigmentierung
US20020182237A1 (en) 2001-03-22 2002-12-05 The Procter & Gamble Company Skin care compositions containing a sugar amine
PL210859B1 (pl) 2001-03-23 2012-03-30 Genencor Int Odmiana subtylizyny zawierająca zmieniony epitop limfocytów T, kwas nukleinowy kodujący tę odmianę subtylizyny, wektor ekspresyjny i komórka gospodarza zawierająca kwas nukleinowy oraz kompozycje zawierające tę odmianę subtylizyny
DE10159245A1 (de) * 2001-12-03 2003-06-18 Degussa Stabile, saure, wässrige Lösung enthaltend alpha-Liponsäure(-Derivate), Verfahren zu deren Herstellung sowie ihre Verwendung
BR0215383A (pt) 2001-12-31 2006-11-28 Genencor Int proteases que produzem resposta imunogênica alterada e métodos de fabricação e uso das mesmas
US7235249B2 (en) 2002-03-28 2007-06-26 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue via topical application of vitamin B6 compositions
DE10257949A1 (de) * 2002-12-12 2004-07-01 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Thiodiglycol
US7098189B2 (en) 2002-12-16 2006-08-29 Kimberly-Clark Worldwide, Inc. Wound and skin care compositions
US20050003024A1 (en) 2003-03-04 2005-01-06 The Procter & Gamble Company Regulation of mammalian hair growth
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US7485666B2 (en) 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
WO2006035320A2 (en) 2004-09-27 2006-04-06 Jan De Rijk Methods and compositions for treatment of water
FR2880802B1 (fr) 2005-01-14 2008-12-19 Sederma Soc Par Actions Simpli Composition cosmetique ou dermopharmaceutique contenant un extrait d'euglene
FR2864540B1 (fr) * 2005-02-22 2010-10-22 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase-related-protein 1 comme agents depigmentants
FR2890310B1 (fr) 2005-09-06 2009-04-03 Sederma Soc Par Actions Simpli Utilisation des protoberberines comme agents regulant l'activite de l'unite pilosebacee
EP3015101B1 (de) 2005-10-03 2019-08-21 PINSKY, Mark A. Non-phospholipid liposomen enthaltend hyaluronsäure
US8404648B2 (en) 2006-02-16 2013-03-26 Sederma Polypeptides KXK and their use
FR2900573B1 (fr) 2006-05-05 2014-05-16 Sederma Sa Nouvelles compositions cosmetiques renfermant au moins un peptide contenant au moins un cycle aromatique bloque
US8287846B2 (en) 2006-07-25 2012-10-16 Zambon S.P.A. Cosmetic or dermatological preparations comprising N-acetylcysteine
EP1886676A1 (de) * 2006-08-09 2008-02-13 Polichem S.A. Zusammensetzungen mit verstärkter elastizierender Aktivität
CN100475189C (zh) 2006-10-17 2009-04-08 王海龙 一种化妆品组合物及其制备方法和应用
FR2910808B1 (fr) * 2006-12-29 2009-04-10 Lvmh Rech Utilisation en cosmetique de la l-2-thiohistidine ou d'un de ses derives comme agent depigmentant.
EP1952845A1 (de) 2007-01-26 2008-08-06 DSMIP Assets B.V. Verwendung eines Astaxathinderivats für kosmetische Zwecke
EP2167028B1 (de) 2007-07-13 2013-04-10 Chanel Parfums Beauté Neue peptid-bleichmittel und diese enthaltende kosmetische zusammensetzungen
FR2939799B1 (fr) 2008-12-11 2011-03-11 Sederma Sa Composition cosmetique comprenant des oligoglucuronanes acetyles.
FR2941232B1 (fr) 2009-01-16 2014-08-08 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
EP3744729B1 (de) 2009-01-16 2023-03-01 Sederma Peptide, zusammensetzungen damit und kosmetische und dermopharmazeutische verwendungen
FR2941231B1 (fr) 2009-01-16 2016-04-01 Sederma Sa Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
FR2944435B1 (fr) 2009-04-17 2011-05-27 Sederma Sa Composition cosmetique comprenant de l'oridonine
FR2945939B1 (fr) 2009-05-26 2011-07-15 Sederma Sa Utilisation cosmetique du dipeptide tyr-arg pour lutter contre le relachement cutane.
CA2785633C (en) * 2009-12-28 2014-07-15 N.V. Perricone Llc Topical acyl glutathione formulations
BR112012031623B1 (pt) 2010-06-11 2018-04-10 The Procter & Gamble Company Composição para cuidados pessoais e seu uso
WO2013083645A2 (en) 2011-12-07 2013-06-13 Unilever Plc Skin lightening composition
US20140328952A1 (en) 2011-12-21 2014-11-06 Dana FLAVIN Topical compositions
US8895041B2 (en) 2012-03-23 2014-11-25 The Procter & Gamble Company Compositions for delivering perfume to the skin
EP3080142B1 (de) 2013-12-10 2018-01-31 Sussex Research Laboratories Inc. Glycopeptidzusammensetzungen und verwendungen davon
CN106572986A (zh) * 2014-03-10 2017-04-19 本杰明·M·余 用于经皮递送的方法和组合物
US20160000682A1 (en) 2014-07-02 2016-01-07 Geoffrey Brooks Consultants Llc Peptide-Based Compositions and Methods of Use
MX376115B (es) 2014-11-10 2025-03-07 Procter & Gamble Composiciones para el cuidado personal con dos fases benéficas.
US10966916B2 (en) 2014-11-10 2021-04-06 The Procter And Gamble Company Personal care compositions
US10085924B2 (en) 2014-11-10 2018-10-02 The Procter & Gamble Company Personal care compositions
US11207248B2 (en) 2014-11-10 2021-12-28 The Procter And Gamble Company Personal care compositions with two benefit phases
WO2019079405A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company AEROSOL FOAMING CLEANSER FOR THE SKIN
WO2019079409A1 (en) 2017-10-20 2019-04-25 The Procter & Gamble Company CLEANER FOR AEROSOL MOUSSE FOAM
EP3720568B1 (de) 2017-12-08 2022-01-12 The Procter & Gamble Company Screening-verfahren für milde hautreiniger
EP3813786A4 (de) 2018-06-27 2022-06-29 Colabs International Corporation Zusammensetzungen mit siliziumdioxidbasierten partikeln, die ein oder mehrere mittel enthalten
WO2020112486A1 (en) 2018-11-29 2020-06-04 The Procter & Gamble Company Methods for screening personal care products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120611A (en) * 1980-02-26 1981-09-22 Pola Chem Ind Inc Beautifying cosmetic
JPS638315A (ja) * 1986-06-28 1988-01-14 Sansho Seiyaku Kk 外用剤
FR2608425B1 (fr) * 1986-12-17 1989-04-28 Rofsa Cerd Composition cosmetique pour la depigmentation selective partielle de la peau et procede pour sa fabrication
JPH0753654B2 (ja) * 1986-12-22 1995-06-07 株式会社肌粧品科学開放研究所 皮膚美白剤
FR2615390B1 (fr) * 1987-05-22 1991-06-14 Leeman Lopes Ginette Procede pour la disparition de taches de para-phenylene-diamine et derives sur la peau et divers substrats

Also Published As

Publication number Publication date
CN1152865A (zh) 1997-06-25
CA2192665A1 (en) 1995-12-21
DE69531863D1 (de) 2003-11-06
KR970703749A (ko) 1997-08-09
MX9606508A (es) 1997-03-29
AU2901995A (en) 1996-01-05
EP0758882A1 (de) 1997-02-26
EP0758882B1 (de) 2003-10-01
CA2192665C (en) 2001-12-18
CZ365996A3 (en) 1997-10-15
WO1995034280A1 (en) 1995-12-21
TW452493B (en) 2001-09-01
AU705904B2 (en) 1999-06-03
JPH10501817A (ja) 1998-02-17

Similar Documents

Publication Publication Date Title
DE69531863D1 (de) Verwendung von n-acetyl-l-cystein zur aufhellung von hyperpigmentierter haut
Torchinskii Sulfhydryl and disulfide groups of proteins
GB1255365A (en) Treatment of keratin fibers
Connett et al. In vitro reaction of the carcinogen chromate with cellular thiols and carboxylic acids
Padgett et al. Cellular responses to nitric oxide: role of protein S-thiolation/dethiolation
Giles et al. Reactive sulphur species: an in vitro investigation of the oxidation properties of disulphide S-oxides
CY1107584T1 (el) Μεθοδοι και συνθεσεις για την προληψη και θepαπεια της αναιμιας
JPH08504822A (ja) スルフヒドリル反応性化合物を用いた毛成長の減少
BR0316437A (pt) Composição cosmeticamente aceitável para tratamento da pele, e, método para tratar a pele
PT734259E (pt) Utilizacao de derivados de piperidina para o tratamento da esquizofrenia
Longoni et al. 1, 25-Dihydroxyvitamin D3 exerts neuroprotective effects in an ex vivo model of mild hyperhomocysteinemia
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
RU2014124197A (ru) Композиции
UA42722C2 (uk) Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить
Biewenga et al. An overview of lipoate chemistry
Hargrove Persulfide generated from L-cysteine inactivates tyrosine aminotransferase. Requirement for a protein with cysteine oxidase activity and gamma-cystathionase.
AU577308B2 (en) Flayene and thioflavene derivative
Torchinskii The chemical properties of SH groups sulfhydryl reagents
NO893249L (no) Cykliske svovelinneholdende forbindelser.
PH24450A (en) 3-methylidene-(thio)flavanones
Puppo et al. The reactivity of thiol compounds with different redox states of leghaemoglobin: evidence for competing reduction and addition pathways
TH18962A (th) สารผสมที่ทำให้ขนร่วงซึ่งประกอบด้วยสารประกอบซัลฟ์ไฮดริล
Banford et al. Differences in the reaction of d-penicillamine and 1-cysteine with 5, 5-dithiobis (2-nitrobenzoic acid). A model for some in vivo differences?
ATE207712T1 (de) Schuh mit schliesslappen und zunge für den rist
Motohashi et al. Modification of γ-irradiation-induced change in myoglobin by α-mercaptopropionylglycine and its related compounds and the formation of sulfmyoglobin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties